The ABCA4 gene, involved in Stargardt disease, has a high percentage of splice-altering pathogenic variants, some of which cause complex RNA defects. Although antisense oligonucleotides (AONs) have shown promising results in splicing modulation, they have not yet been used to target complex splicing defects. Here, we performed AON-based rescue studies on ABCA4 complex splicing defects. Intron 13 variants c.1938-724A>G, c.1938-621G>A, c.1938-619A>G, and c.1938-514A>G all lead to the inclusion of different pseudo-exons (PEs) with and without an upstream PE (PE1). Intron 44 variant c.6148-84A>T results in multiple PE inclusions and/or exon skipping events. Five novel AONs were designed to target these defects. AON efficacy was assessed by in vitro splice assays using midigenes containing the variants of interest. All screened complex splicing defects were effectively rescued by the AONs. Although varying levels of efficacy were observed between AONs targeting the same PEs, for all variants at least one AON restored splicing to levels comparable or better than wildtype. In conclusion, AONs are a promising approach to target complex splicing defects in ABCA4.
Get full access to this article
View all access options for this article.
References
1.
CideciyanAV, SwiderM, AlemanTS, et al.ABCA4-associated retinal degenerations spare structure and function of the human parapapillary retina. Invest Ophthalmol Vis Sci, 2005; 46:4739–4746.
2.
AabergTM. Stargardt’s disease and fundus flavimaculatus: Evaluation of morphologic progression and intrafamilial co-existence. Trans Am Ophthalmol Soc, 1986; 84:453–487.
3.
AllikmetsR, SinghN, SunH, et al.A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet, 1997; 15:236–246.
4.
MoldayLL, RabinAR, MoldayRS. ABCR expression in foveal cone photoreceptors and its role in stargardt macular dystrophy. Am J Ophthalmol, 2000; 130:689.
5.
IllingM, MoldayLL, MoldayRS. The 220-kDa rim protein of retinal rod outer segments is a member of the ABC transporter superfamily. J Biol Chem, 1997; 272:10303–10310.
6.
LenisTL, HuJ, NgSY, et al.Expression of ABCA4 in the retinal pigment epithelium and its implications for stargardt macular degeneration. Proc Natl Acad Sci U S A, 2018; 115:E11120–E11127.
7.
QuaziF, LenevichS, MoldayRS. ABCA4 is an N-retinylidene-phosphatidylethanolamine and phosphatidylethanolamine importer. Nat Commun, 2012; 3:925.
8.
MoldayRS, ZhongM, QuaziF. The role of the photoreceptor ABC transporter ABCA4 in lipid transport and Stargardt macular degeneration. Biochim Biophys Acta, 2009; 1791:573–583.
9.
CornelisSS, BauwensM, Haer-WigmanL, et al.Compendium of clinical variant classification for 2,247 unique ABCA4 variants to improve genetic medicine access for Stargardt disease. medRxiv, 2023; doi: 10.1101/2023.04.24.23288782
10.
CornelisSS, RunhartEH, BauwensM, et al.Personalized genetic counseling for stargardt disease: Offspring risk estimates based on variant severity. American Journal of Human Genetics, 2022; 109:498–507.
11.
CremersFPM, LeeW, CollinRWJ, et al.Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations. Prog Retin Eye Res, 2020; 79.
12.
BauwensM, GarantoA, SangermanoR, et al.ABCA4-associated disease as a model for missing heritability in autosomal recessive disorders: Novel noncoding splice, cis-regulatory, structural, and recurrent hypomorphic variants. Genet Med, 2019; 21:1761–1771.
13.
KhanM, CornelisSS, Pozo-ValeroMD, et al.Resolving the dark matter of ABCA4 for 1054 stargardt disease probands through integrated genomics and transcriptomics. Genet Med, 2020; 22:1235–1246.
14.
SchulzHL, GrassmannF, KellnerU, et al.Mutation spectrum of the ABCA4 gene in 335 stargardt disease patients from a multicenter German cohort-impact of selected deep intronic variants and common SNPs. Investigative Ophthalmology & Visual Science, 2017; 58:394–403.
15.
SangermanoR, GarantoA, KhanM, et al.Deep-intronic ABCA4 variants explain missing heritability in stargardt disease and allow correction of splice defects by antisense oligonucleotides. Genet Med, 2019; 21:1751–1760.
16.
SangermanoR, KhanM, CornelisSS, et al.ABCA4 midigenes reveal the full splice spectrum of all reported noncanonical splice site variants in stargardt disease. Genome Res, 2018; 28:100–110.
17.
KaltakM, CorradiZ, CollinRWJ, et al.Stargardt disease-associated missense and synonymous ABCA4 variants result in aberrant splicing. Hum Mol Genet, 2023; 32:3078–3089.
18.
AlbertS, GarantoA, SangermanoR, et al.Identification and rescue of splice defects caused by two neighboring deep-intronic ABCA4 mutations underlying stargardt disease. American Journal of Human Genetics, 2018; 102:517–527.
19.
GarantoA, DuijkersL, TomkiewiczTZ, et al.Antisense oligonucleotide screening to optimize the rescue of the splicing defect caused by the recurrent deep-intronic ABCA4 variant c.4539 + 2001G>a in stargardt disease. Genes (Basel), 2019; 10:10.
20.
TomkiewiczTZ, Suarez-HerreraN, CremersFPM, et al.Antisense oligonucleotide-based rescue of aberrant splicing defects caused by 15 pathogenic variants in ABCA4. Int J Mol Sci, 2021; 22.
21.
CollinRW, den HollanderAI, van der Velde-VisserSD, et al.Antisense Oligonucleotide (AON)-based therapy for leber congenital amaurosis caused by a frequent mutation in CEP290. Mol Ther Nucleic Acids, 2012; 1:e14.
22.
GerardX, PerraultI, HaneinS, et al.AON-mediated exon skipping restores ciliation in fibroblasts harboring the common leber congenital amaurosis CEP290 mutation. Mol Ther Nucleic Acids, 2012; 1:e29.
23.
GarantoA, ChungDC, DuijkersL, et al.In vitro and in vivo rescue of aberrant splicing in CEP290-associated LCA by antisense oligonucleotide delivery. Hum Mol Genet, 2016; 25:2552–2563.
24.
DullaK, AguilaM, LaneA, et al.Splice-Modulating oligonucleotide QR-110 restores CEP290 mRNA and function in human c.2991 + 1655A>G LCA10 models. Mol Ther Nucleic Acids, 2018; 12:730–740.
25.
DuijkersL, van den BornLI, NeidhardtJ, et al.Antisense oligonucleotide-based splicing correction in individuals with leber congenital amaurosis due to compound heterozygosity for the c.2991 + 1655A>G mutation in CEP290. Int J Mol Sci, 2018; 19.
26.
SlijkermanRW, VacheC, DonaM, et al.Antisense oligonucleotide-based splice correction for USH2A-associated retinal degeneration caused by a frequent deep-intronic mutation. Mol Ther Nucleic Acids, 2016; 5:e381.
27.
GarantoA, van der Velde-VisserSD, CremersFPM, et al.Antisense oligonucleotide-based splice correction of a deep-intronic mutation in CHM underlying choroideremia. Adv Exp Med Biol, 2018; 1074:83–89.
28.
BonifertT, Gonzalez MenendezI, BattkeF, et al.Antisense oligonucleotide mediated splice correction of a deep intronic mutation in OPA1. Mol Ther Nucleic Acids, 2016; 5:e390.
29.
FadaieZ, KhanM, Del Pzo-oValeroM, et al.Identification of splice defects due to noncanonical splice site or deep-intronic variants in ABCA4. Hum Mutat, 2019; 40:2365–2376.
30.
GarantoA, CollinRWJ. Design and in vitro use of antisense oligonucleotides to correct pre-mRNA splicing defects in inherited retinal dystrophies. Methods Mol Biol, 2018; 1715:61–78.
31.
Aartsma-RusA. Overview on AON design. Methods Mol Biol, 2012; 867:117–129.
32.
SchneiderCA, RasbandWS, EliceiriKW. NIH image to imagej: 25 years of image analysis. Nat Methods, 2012; 9:671–675.
33.
BraunTA, MullinsRF, WagnerAH, et al.Non-exomic and synonymous variants in ABCA4 are an important cause of stargardt disease. Hum Mol Genet, 2013; 22:5136–5145.
34.
RossbachO, HungLH, SchreinerS, et al.Auto- and cross-regulation of the hnRNP L proteins by alternative splicing. Mol Cell Biol, 2009; 29:1442–1451.
35.
LareauLF, InadaM, GreenRE, et al.Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. Nature, 2007; 446:926–929.
36.
HafezM, HausnerG. Convergent evolution of twintron-like configurations: One is never enough. RNA Biol, 2015; 12:1275–1288.
37.
SibleyCR, EmmettW, BlazquezL, et al.Recursive splicing in long vertebrate genes. Nature, 2015; 521:371–375.
38.
HoppeER, UdyDB, BradleyRK. Recursive splicing discovery using lariats in total RNA sequencing. Life Sci Alliance, 2023; 6.
39.
KeeganNP, WiltonSD, FletcherS. Analysis of pathogenic pseudoexons reveals novel mechanisms driving cryptic splicing. Front Genet, 2021; 12:806946.
40.
KimJ, HuC, Moufawad El AchkarC, et al.Patient-customized oligonucleotide therapy for a rare genetic disease. N Engl J Med, 2019; 381:1644–1652.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
